Post-earnings recap
Reported
Tue, Aug 4, 2026
EPS actual
$3.05
EPS est.
$3.01
EPS surprise
+1.43%
1-day move
+5.69%
Waters Corporation reported better-than-expected earnings per share, which contributed to a positive stock reaction, with shares rising by 5.69%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may be encouraged by the EPS beat, but the lack of revenue data and guidance could lead to cautious sentiment going forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.05 | $3.01 | +1.43% |
| Revenue | N/A | $1.6B | N/A |
No transcript is on record, and the analysis is based on numerical results only.
Waters Corporation (WAT) operates in the health care sector, specifically within life sciences tools and services. The company is known for its innovative analytical instruments and software, which are crucial for laboratories in pharmaceuticals, biotechnology, and environmental testing. As the demand for precision in scientific research and quality control grows, Waters plays a significant role in supporting these industries.
Last quarter
In Q1-2026, Waters Corporation reported an EPS of $2.70, exceeding expectations by 17.09%. The stock reacted positively, gaining 13.54% the following day.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+4.85%
Avg 1-day reaction
+2.67%
Analysts expect Waters to deliver solid earnings this quarter, with a consensus EPS of $3.01. The company's strong track record of beating earnings estimates has set a positive tone heading into the report.
Bull case
If Waters exceeds EPS expectations and demonstrates strong revenue growth, it could signal robust demand for its products, leading to a further increase in stock price.
Bear case
Conversely, if the company fails to meet expectations or provides weak guidance, it could raise concerns about future growth and negatively impact the stock.
Key metrics to watch
EPS
$3.01Earnings per share is a key indicator of profitability and is closely watched by investors.
Revenue
$1.6BRevenue figures provide insight into the company's sales performance and market demand.
The print will turn on these.
Q1
Will the EPS exceed the consensus estimate of $3.01?
A beat on EPS would reinforce investor confidence and could lead to a positive stock reaction.
Q2
What guidance will management provide for future revenue growth?
Guidance on revenue growth is crucial for assessing the company's outlook and could significantly impact stock performance.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±12.7%
Why consensus could be wrong
The consensus may underestimate the potential for Waters to exceed EPS expectations due to its strong historical performance and recent product innovations.
Supporting evidence
Waters has consistently beaten EPS estimates in the last eight quarters, suggesting a trend of strong performance.
The options market is pricing a smaller move than historical averages, indicating potential undervaluation.
Recent industry trends show increased demand for analytical instruments, which could benefit Waters.
Key risk
If revenue growth exceeds expectations, it could invalidate the cautious outlook reflected in current estimates.
Pre-commit to what would confirm each case.
The market is debating whether Waters can maintain its growth trajectory in a competitive landscape, with expectations set high based on historical performance.
Bull confirmed if
An EPS of $3.05 or higher would confirm strong demand and operational efficiency.
Bear confirmed if
An EPS below $2.98 would raise concerns about market conditions and company performance.
What the market is pricing for the move.
Implied Move
±4.4%
Historical Avg
±8.3%
The options market is pricing in a moderate move around the earnings report, suggesting some uncertainty but not extreme volatility.
Options are pricing a 4.4% move, while the stock has averaged an 8.3% move historically, indicating a potentially undervalued setup.
ATM IV
0.4%
30d HV
57.9%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options cheap in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
102.08%
of float
Insider
0.10%
of float
Holders
1,614
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
8,484,939 sh · $3.7B
8.64%
-0.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Waters beats expectations, history suggests a potential stock increase of around 2.29%, confirming strong demand and operational success.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting uncertainty about future growth.
Miss
A miss could lead to a decline in stock price, with historical patterns suggesting an average drop of around 2.29%.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
1
0 buys·1 sell
Members
1
House only
Est. Notional
$1,001.00–$15,000.00
disclosed dollar ranges
Most Active Members
1 trade
The lines on the call that would change the story.
Vanguard Capital Management LLC
6,415,552 sh · $2.8B
6.53%
0.6%
Vanguard Portfolio Management LLC
4,740,524 sh · $2.1B
4.83%
-0.3%
Massachusetts Financial Services Co.
4,625,035 sh · $2.0B
4.71%
-0.1%
State Street Corporation
4,382,008 sh · $1.9B
4.46%
0.5%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Net selling
Recent Transactions
Traded Aug 13, 2026 · disclosed Sep 1, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.